Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 8/2012

01-08-2012 | Stanford Multidisciplinary Seminars

Sump Syndrome as a Complication of Choledochoduodenostomy

Authors: Motaz Qadan, Sharon Clarke, Ellen Morrow, George Triadafilopoulos, Brendan Visser

Published in: Digestive Diseases and Sciences | Issue 8/2012

Login to get access

Excerpt

A 71-year-old man initially underwent open cholecystectomy for biliary colic in 1990. Since then, he had been well until new symptoms began in 2009, when he presented to a community hospital reporting intermittent epigastric pain; ultrasound and computed tomography (CT) scans revealed choledocholithiasis. …
Literature
1.
Riedel H. Uber den zungenfoermigen fortastz des recchten lebberlappens und seine pathognostiche bedentung fur die, erkrankungen der gallenblose nebst bemerkungen gallenstein operationen. Berl Klin Wochenschr. 1888;25:577.
2.
Sprengel O. Uber einen fall von extirpation der gallenblase mit anlegung einer kommunikation zwischen ductus choledochus und duodenum. Arch Klin Chir. 1891;124:1913.
3.
Leppard WM, Shary TM, Adams DB, Morgan KA. Choledochoduodenostomy: is it really so bad? J Gastrointest Surg. 2011;15:754.PubMedCrossRef
4.
Sanders RL. Indications for and value of choledochoduodenostomy. Ann Surg. 1946;123:847.CrossRef
5.
Jeyapalan M, Almeida JA, Michaelson RL, Franklin ME Jr. Laparoscopic choledochoduodenostomy: review of a 4-year experience with an uncommon problem. Surg Laparosc Endosc Percutan Tech. 2002;12:148.PubMedCrossRef
6.
Birkenfeld S, Serour F, Dona G, Krispin M. Choledochoduodenostomy for benign biliary tract disease in the elderly. Am Surg. 1987;53:658.PubMed
7.
Lygidakis NJ. Surgical approaches to recurrent choledocholithiasis. Choledochoduodenostomy versus T-tube drainage after choledochotomy. Am J Surg. 1983;145:636.PubMedCrossRef
8.
de Aretxabala X, Bahamondes JC. Choledochoduodenostomy for common bile duct stones. World J Surg. 1998;22:1171.PubMedCrossRef
9.
Zinner MJ Jr, Ashley SW. Maingot’s Abdominal Operations. 11th ed. New York: McGraw-Hill; 2007.
10.
Thomas E, Grant AK, Holford M, Ringwood D, Derrington AW, Magarey JR. Bacterial flora in the duodenum of patients after biliary fenestration. Br J Surg. 1973;60:107.PubMedCrossRef
11.
Huang T, Bass JA, Williams RD. The significance of biliary pressure in cholangitis. Arch Surg. 1969;98:629.PubMedCrossRef
12.
Baker AR, Neoptolemos JP, Carr-Locke DL, Fossard DP. Sump syndrome following choledochoduodenostomy and its endoscopic treatment. Br J Surg. 1985;72:433.PubMedCrossRef
13.
de Almeida AM, Cruz AG, Aldeia FJ. Side-to-side choledochoduodenostomy in the management of choledocholithiasis and associated disease. Facts and fiction. Am J Surg. 1984;147:253.PubMedCrossRef
14.
Madden JL, Chun JY, Kandalaft S, Parekh M. Choledochoduodenostomy: an unjustly maligned surgical procedure? Am J Surg. 1970;119:45.PubMedCrossRef
15.
Hawes DR, Pelsang RE, Janda RC, Lu CC. Imaging of the biliary sump syndrome. AJR Am J Roentgenol. 1992;158:315.PubMed
16.
Siegel JH. Duodenoscopic sphincterotomy in the treatment of the “sump syndrome”. Dig Dis Sic. 1981;26:922.CrossRef
17.
Marbet UA, Stalder GA, Faust H, Harder F, Gyr K. Endoscopic sphincterotomy and surgical approaches in the treatment of the ‘sump syndrome’. Gut. 1987;28:142.PubMedCrossRef
18.
Hallstone A, Triadafilopoulos G. “Spontaneous sump syndrome”: successful treatment by duodenoscopic sphincterotomy. Am J Gastroenterol. 1990;85:1518.PubMed
19.
Caroli-Bosc FX, Demarquay JF, Peten EP, et al. Endoscopic management of sump syndrome after choledochoduodenostomy: retrospective analysis of 30 cases. Gastrointest Endosc. 2000;51:180.PubMedCrossRef
Metadata
Title
Sump Syndrome as a Complication of Choledochoduodenostomy
Authors
Motaz Qadan
Sharon Clarke
Ellen Morrow
George Triadafilopoulos
Brendan Visser
Publication date
01-08-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-2020-4

Other articles of this Issue 8/2012

Digestive Diseases and Sciences 8/2012 Go to the issue

Original Article

Effect of the Expression of Matrix Metalloproteases and Their Tissue Inhibitors on Survival of Patients with Resectable Colorectal Cancer

Editorial

Understanding the Role of PNPLA3 Genetic Variants in Patients with Chronic Hepatitis C Infection

Original Article

Fecal M2-PK in Children with Crohn’s Disease: A Preliminary Report

Editorial

Does the Human Gut Microbiota Contribute to the Etiology of Autism Spectrum Disorders?

Original Article

Prenatal and Perinatal Characteristics Associated with Pediatric-Onset Inflammatory Bowel Disease

Rapid Communications

Evaluating the Feasibility of Direct Peroral Cholangioscopy Training with an Endoscopic Simulator
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits